Pelvic lipomatosis

Pelvic lipomatosis is a rare disease characterized by overgrowth of fat cells in the pelvic region. It is often associated with various urinary and gastrointestinal symptoms. The disease is most commonly seen in middle-aged African American men, but it can affect individuals of any race or age.

Symptoms and Signs

The symptoms of pelvic lipomatosis can vary greatly from person to person. Some individuals may experience no symptoms at all, while others may have severe urinary and gastrointestinal problems. Common symptoms include:

• Urinary frequency
• Urinary urgency
• Urinary incontinence
• Constipation
• Abdominal pain
• Lower back pain

Causes

The exact cause of pelvic lipomatosis is unknown. However, it is believed to be related to chronic inflammation in the pelvic region. Some researchers have suggested that it may be an autoimmune response, while others believe it may be related to obesity or a high-fat diet.

Diagnosis

Diagnosis of pelvic lipomatosis is typically made through a combination of physical examination, medical history, and imaging studies. Computed tomography (CT) scans and magnetic resonance imaging (MRI) are often used to visualize the extent of the fat overgrowth.

Treatment

Treatment for pelvic lipomatosis is primarily aimed at managing symptoms. This may include medications to control urinary and gastrointestinal symptoms, as well as lifestyle changes such as weight loss and dietary modifications. In severe cases, surgery may be necessary to remove excess fat.

Prognosis

The prognosis for individuals with pelvic lipomatosis is generally good, although the disease can cause significant discomfort and impact quality of life. With appropriate treatment, most individuals can manage their symptoms and lead normal lives.

See also

• Lipomatosis
• Pelvic pain
• Urinary incontinence
• Constipation

Pelvic lipomatosis Resources
Latest articles Most recent articles Ongoing trials	Wikipedia

References

External links

• Pelvic Lipomatosis at PubMed
• Pelvic Lipomatosis at National Organization for Rare Disorders (NORD)